These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 26784140)

  • 1. Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?
    Goossens N; Hoshida Y
    Gastroenterology; 2016 Jun; 150(8):1710-7. PubMed ID: 26784140
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: the NCAN-PNPLA3-lipid connection?
    Nault JC; Nahon P
    J Hepatol; 2014 Nov; 61(5):971-2. PubMed ID: 25111177
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Anstee QM; Liu YL; Day CP; Reeves HL
    J Hepatol; 2015 Apr; 62(4):982-3. PubMed ID: 25559329
    [No Abstract]   [Full Text] [Related]  

  • 5. HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
    Krawczyk M; Stokes CS; Romeo S; Lammert F
    J Hepatol; 2015 Apr; 62(4):980-1. PubMed ID: 25559327
    [No Abstract]   [Full Text] [Related]  

  • 6. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.
    Dongiovanni P; Romeo S; Valenti L
    World J Gastroenterol; 2014 Sep; 20(36):12945-55. PubMed ID: 25278690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Massoud O; Charlton M
    Clin Liver Dis; 2018 Feb; 22(1):201-211. PubMed ID: 29128057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B; Qiao L; Hebbard L
    World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the etiology-associated gene regulatory networks in hepatocellular carcinoma from The Cancer Genome Atlas.
    Seshachalam VP; Sekar K; Hui KM
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2037-2047. PubMed ID: 29672926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.
    Marengo A; Jouness RI; Bugianesi E
    Clin Liver Dis; 2016 May; 20(2):313-24. PubMed ID: 27063271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.
    Chan AW; Wong GL; Chan HY; Tong JH; Yu YH; Choi PC; Chan HL; To KF; Wong VW
    J Gastroenterol Hepatol; 2017 Mar; 32(3):667-676. PubMed ID: 27547913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.
    Kutlu O; Kaleli HN; Ozer E
    Can J Gastroenterol Hepatol; 2018; 2018():8543763. PubMed ID: 30228976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?
    Joshi K; Kohli A; Manch R; Gish R
    Clin Liver Dis; 2016 Aug; 20(3):563-80. PubMed ID: 27373617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment.
    Argyrou C; Moris D; Vernadakis S
    J BUON; 2017; 22(1):6-20. PubMed ID: 28365930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of Alcoholic Liver Disease.
    Anstee QM; Daly AK; Day CP
    Semin Liver Dis; 2015 Nov; 35(4):361-74. PubMed ID: 26676812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Zhang C; Wang P; Li Y; Huang C; Ni W; Chen Y; Shi J; Chen G; Hu X; Ye M; Duan S; Wang K
    Anat Rec (Hoboken); 2019 Feb; 302(2):193-200. PubMed ID: 30312023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of the hepatocellular carcinoma in alcoholic liver disease].
    Izumi N
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1651-6. PubMed ID: 26346355
    [No Abstract]   [Full Text] [Related]  

  • 20. N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease.
    Agúndez JA; Ladero JM; Olivera M; Lozano L; Fernández-Arquero M; de laConcha EG; Díaz-Rubio M; Benitez J
    Scand J Gastroenterol; 2002 Jan; 37(1):99-103. PubMed ID: 11858170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.